{"disease":{"id":"tyrosinemia-type-iii","name":"tyrosinemia type iii"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04196959","title":"Evaluation of TYR Sphere","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Vitaflo International, Ltd","has_results":false},{"nct_id":"NCT06298292","title":"Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"metaX Institut fuer Diatetik GmbH","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}